We are live on ! Find out more
SK

Seth Klarman Baupost Group

AUM $5.42B
1-Year Est. Return 22.93%
 

Seth Klarman is the founder and CEO of the Baupost Group, one of the most respected value-oriented investment firms. He is the author of Margin of Safety and is known for patient, opportunistic capital allocation across equities, credit, and special situations. Klarman’s approach emphasizes downside protection, cash when opportunities are scarce, and independent thinking when markets become crowded.

This Fund
S&P 500
This Quarter Est. Return
+8.09%
1 Year Est. Return
+22.93%
3 Year Est. Return
+47.86%
5 Year Est. Return
+25.7%
10 Year Est. Return
+163.46%
AUM
$4.14B
AUM Growth
+$608M
Cap. Flow
+$456M
Cap. Flow %
11.01%
Top 10 Hldgs %
92.24%
Holding
23
New
4
Increased
4
Reduced
2
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 50.31%
2 Healthcare 20.66%
3 Energy 14.76%
4 Materials 2.06%
5 Consumer Staples 0.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
1
Micron Technology
MU
$1.09T
$1.22B 29.54%
51,655,434
VSAT icon
2
Viasat
VSAT
$10.3B
$787M 19.02%
11,395,900
+266,700
+2% +$17.3M
INVA icon
3
Innoviva
INVA
$1.52B
$641M 15.49%
25,695,899
+696,821
+3% +$20.4M
LNG icon
4
Cheniere Energy
LNG
$57.3B
$313M 7.57%
+5,660,000
New +$271M
IDIX
5
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$303M 7.32%
53,331,109
+16,420,241
+44% +$115M
BP icon
6
BP
BP
$115B
$152M 3.68%
3,871,089
-3,056,368
-44% -$121M
PBF icon
7
PBF Energy
PBF
$8.72B
$140M 3.38%
5,416,606
+3,440,000
+174% +$91.4M
KERX
8
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$108M 2.6%
+6,310,850
New +$95.2M
NG icon
9
NovaGold Resources
NG
$3.83B
$78.3M 1.89%
21,688,300
IMOS
10
ChipMOS TECHNOLOGIES
IMOS
$1.88B
$72.4M 1.75%
2,979,654
C.WS.A
11
DELISTED
Citigroup Inc
C.WS.A
$66.9M 1.62%
104,246,007
RFMD
12
DELISTED
RF MICRO DEVICES INC
RFMD
$51.9M 1.25%
+6,585,000
New +$40.5M
TQNT
13
DELISTED
TRIQUINT SEMICONDUCTOR INC
TQNT
$51.2M 1.24%
+3,825,000
New +$39.7M
KIN
14
DELISTED
Kindred Biosciences, Inc.
KIN
$51.2M 1.24%
2,763,848
-136,152
-5% -$2.6M
ELOS
15
DELISTED
Syneron Medical Ltd
ELOS
$49.8M 1.2%
4,000,000
AOI
16
DELISTED
Alliance One International
AOI
$18.6M 0.45%
638,364
AIG.WS
17
DELISTED
American International Group, Inc.
AIG.WS
$13.4M 0.32%
656,443
TMQ
18
Trilogy Metals
TMQ
$684M
$6.76M 0.16%
5,005,298
AVEO
19
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$5.72M 0.14%
382,935
ALDW
20
DELISTED
Alon USA Partners LP
ALDW
$5.48M 0.13%
329,188
FNF icon
21
Fidelity National Financial
FNF
$12.7B
-3,458,214
Closed -$64.1M
TIVO
22
DELISTED
Tivo Inc
TIVO
-2,160,000
Closed -$42.5M
ENZN
23
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
-4,337,858
Closed -$5.03M

Similar funds

Seth Klarman's Q1 2014 Portfolio in Review

As of Q1 2014, Seth Klarman held 23 positions worth $4.14B, up 17% from $3.53B the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Seth Klarman deployed $456M of net new capital in Q1 2014, opening 4 new positions and adding to 4 existing holdings. Its largest new stake was Cheniere Energy: 5,660,000 shares worth $313M.

By sector, the portfolio is most concentrated in Technology at 50% of assets, down from 53% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was BP, an estimated $121M trimmed.

  • Seth Klarman's largest Q1 2014 buy was Cheniere Energy: 5,660,000 shares worth $313M.
  • Seth Klarman added most to IDENIX PHARMACEUTICALS INC in Q1 2014, an estimated $115M increase.
  • Seth Klarman's biggest Q1 2014 reduction was BP, cutting an estimated $121M.
  • Seth Klarman fully exited Fidelity National Financial in Q1 2014, selling an estimated $64.1M.
  • Seth Klarman's ten largest holdings make up 92% of its $4.14B portfolio in Q1 2014.
  • Seth Klarman opened 4 new positions and closed 3 in Q1 2014.
  • Seth Klarman's portfolio value rose 17% quarter-over-quarter to $4.14B.

Based on Baupost Group's 13F filing for Q1 2014, filed 14 May 2014.